The effect is much less with histamine type-2 blockers, such as cimetidine (Tagamet) or famotidine (Pepcid). There can still ...

Targeting both patients and physicians with information about deprescribing proton pump inhibitors may be more effective than communicating with physicians alone.

In a recent study published in Neurology, researchers determine whether the current and cumulative use of prescription proton pump inhibitors (PPIs) increases the risk of incident dementia. Study: ...

Use of proton pump inhibitors appears to increase the risk for kidney failure among patients with CKD. Use of proton pump inhibitors (PPIs) may spur progression to kidney failure in patients with ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am a retired male over 65 and a former occasional cigar ...

Patient- and physician-facing interventions together doubled the reductions in PPI use ...

Please provide your email address to receive an email when new articles are posted on . Findings showed use was associated with fatigue and lower health-related quality of life. The associations were ...

A recent Scientific Reports study investigates whether the association between proton pump inhibitors (PPIs) and the use of histamine-2 receptor antagonists (H2RA) affects the risk of chronic kidney ...

Nearly 70% of patients with acute upper gastrointestinal (GI) bleeding and low-risk or no peptic ulcer disease received intravenous (IV) proton pump inhibitors (PPIs) inappropriately, leading to ...

A French trial found that combining patient education with a physician deprescribing algorithm doubled the rate of halving proton pump inhibitor (PPI) use compared with usual care or physician-only ...

Proton pump inhibitors (PPIs) were strongly linked with serious infection risk among infants and young children in a large national study, suggesting caution in prescribing. In more than one million ...